Insulin Glargine in Type 2 Diabetes
NCT00268645
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
534
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Insulin Glargine
Sponsor
Sanofi